Abstract
We focus on distinctive data-driven measures of the fate of ongoing epidemics. The relevance of our pursuit is suggested by recent results proving that the short-term temporal evolution of infection spread is described by an epidemicity index related to the maximum instantaneous growth rate of new infections, echoing concepts and tools developed to study the reactivity of ecosystems. Suitable epidemicity indices can showcase the dynamics of infections, together with commonly employed effective reproduction numbers, especially when the latter assume values less than 1. In particular, epidemicity evaluates the short-term reactivity to perturbations of a disease-free equilibrium. Here, we show that sufficient epidemicity thresholds to prevent transient epidemic outbreaks in a spatially connected setting can be estimated by generalizing existing analogues derived when spatial effects are neglected. We specifically account for the discrete nature, in both space and time, of surveillance data of the type typically employed to estimate effective reproduction numbers that formed the bulk of the communication of the state of the COVID-19 pandemic and its controls. After analyzing the effects of spatial heterogeneity on the considered prognostic indicators, we perform a short- and long-term analysis on the COVID-19 pandemic in Italy, showing that endemic conditions were maintained throughout the duration of our simulation despite stringent control measures. Our method provides a portfolio of prognostic indices that are essential to pinpoint the ongoing pandemic in both a qualitative and quantitative manner, as our results demonstrate. We base our conclusions on extended investigations of the effects of spatial fragmentation of communities of different sizes owing to connectivity by human mobility and contact scenarios, within real geographic contexts and synthetic setups designed to test our framework.
Author summary We revisit current standards in the characterization of the instantaneous state of epidemic spread in the light of newly acquired capabilities relaxing the assumption of spatially implicit disease geographies. Specifically, we generalize data-driven estimators of short-term epidemicity to include remotely acquired and objectively manipulated information about human mobility and the ensuing contacts between infected and susceptible individuals. Our results show that a spatial perspective can provide useful information on each node’s contribution to unfolding epidemics in connected systems. The level of heterogeneity that implies major departures among the key indicators, in particular epidemicity indices measuring the maximum growth rates of new infections (whose spatially explicit version is derived here), is identifiable and not unrealistic. Therefore, we suggest that only a portfolio of indicators based on epidemiological data (spatially implicit and explicit effective reproduction numbers and epidemicity indices that address the reactivity of the system) can provide a general, time-varying, and comprehensive overview of the effectiveness of epidemic control.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
C.T., and A.R. acknowledge funding from the Swiss National Science Foundation (https://www.snf.ch/en) via the project "Optimal control of intervention strategies for waterborne disease epidemics" (grant number 200021-172578). L.M. acknowledges funding from the Italian Ministry of University and Research (https://www.mur.gov.it/it) through the project "Epidemiological data assimilation and optimal control for short-term forecasting and emergency management of COVID-19 in Italy" (FISR 2020IP 04249). All sponsors have not had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* cristiano.trevisin{at}epfl.ch
Data availability statement
All codes and data involved in this study are available at the following public GitHub repository: https://github.com/cristianotrevisin/epidemiological-indices-metapopulation.
